• OPEN AN ACCOUNT
Indian Indices
Sensex
78,499.17 -455.59
( -0.58%)
Global Indices
Nasdaq
53,904.84 -465.28
(-0.86%)
Dow Jones
7,729.00 -15.55
(-0.20%)
Hang Seng
65,597.55 -85.71
(-0.13%)
Nikkei 225
10,909.12 41.23
(0.38%)
Forex
USD-INR
95.07 -0.16
(-0.17%)
EUR-INR
109.74 0.07
(0.06%)
GBP-INR
127.99 0.00
(0.00%)
JPY-INR
0.60 0.00
(-0.16%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.6032787
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
33.93
65.19
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

Hemo Organic reports standalone net loss of Rs 0.51 crore in the March 2026 quarter
May 30,2026
Net loss of Hemo Organic reported to Rs 0.51 crore in the quarter ended March 2026 as against net profit of Rs 0.37 crore during the previous quarter ended March 2025. Sales declined 61.41% to Rs 0.93 crore in the quarter ended March 2026 as against Rs 2.41 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.78 crore in the year ended March 2026 as against net profit of Rs 0.16 crore during the previous year ended March 2025. Sales declined 61.41% to Rs 0.93 crore in the year ended March 2026 as against Rs 2.41 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.932.41 -61 0.932.41 -61
OPM %-32.265.81 --53.76-2.07 -
PBDT-0.300.23 PL -0.500.02 PL
PBT-0.300.23 PL -0.500.02 PL
NP-0.510.37 PL -0.780.16 PL